Atlas Trials

Study of COVID-19 DNA Vaccine (AG0301-COVID19)

Clinical trial NCT04463472 · COMPLETED

Trial details

NCT number
NCT04463472
Sponsor
AnGes, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-06-29
Primary completion
2020-09-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.